RYR2 and Alzheimer disease: Notably, the elevated RyR2 expression, cognitive decline, and synaptic loss observed in patients with MCI, are mirrored by increased RyR2 expression and Ca2+ release in presymptomatic AD mice [12], [13], [20], [21].